Leukocyte adhesion deficiencies

Annals of the New York Academy of Sciences

Volumn 1250, Issue 1, 2012, Pages 50-55

  Hanna, Suhair ^a   Etzioni, Amos ^a  

^a MEYER CHILDREN S HOSPITAL   (Israel)

Author keywords

adhesion cascade; Fucose; Integrin; Kindlin 3; Leukocyte adhesion deficiency

Indexed keywords

BETA1 INTEGRIN; BETA2 INTEGRIN; BETA3 INTEGRIN; CD18 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; SELECTIN; SIALYL LEWIS X ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; BLOOD TRANSFUSION; CELL MIGRATION; CLINICAL FEATURE; CONGENITAL DISORDER OF GLYCOSYLATION TYPE 2C; DISEASE SEVERITY; ENDOTHELIUM; GENE MUTATION; GINGIVITIS; GOLGI COMPLEX; GRANULOCYTOSIS; HUMAN; LEUKOCYTE ADHERENCE; LEUKOCYTE ADHESION DEFICIENCY; LEUKOCYTE ADHESION DEFICIENCY TYPE III; LEUKOCYTOSIS; NEUTROPHIL COUNT; PERIODONTITIS; RECURRENT INFECTION;

ANIMALIA;

EID: 84857478993     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2011.06389.x     Document Type: Article

References (46)

1. Ley, K., V. Luadanna, M.I. Cybulsky & E. Nourshargh 2007. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat. Rev. Immunol. 7: 678-689.
2. Etzioni, A. 2007. Leukocyte adhesion deficiencies: molecular basis, clinical findings and therapeutic options. Adv. Exp. Med. Biol. 601: 51-60.
3. McEver, R.P. 2002. Lectins that initiate cell adhesion under flow. Curr. Opin. Cell. Biol. 14: 581-586.
4. Lawrence, M.B. & T.A. Springer 1991. Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins. Cell. 65: 859-873.
5. Abram, C.L. & C.A. Lowell 2007. The ins and outs of leukocyte integrin signaling. Annu. Rev. Immunol. 7: 790-802.
6. Etzioni, A. 2009. Genetic etiologies of leukocyte adhesion defects. Curr. Opin. Immunol. 21: 481-486.
7. Crowley, C.A., J.T. Curnutte, R.E. Rosin, et al 1980. An inherited abnormality of neutrophil adhesion. Its genetic transmission and its association with a missing protein. N. Engl. J. Med. 302: 1163-1168.
8. Movahedi, M., N. Entezari, Z. Pourpak, et al 2008. Clinical and laboratory findings in Iranian patients with leukocyte adhesion deficiency (study of 15 cases). J. Clin. Immunol. 28: 92.
9. Andersen, D.C. & C.W. Smith 2001. Leukocyte adhesion deficiencies. In The Metabolic and Molecular Basis of Inherited Diseases, 8th ed. C. Scriver, A. Beaudet, W. Sly & D. Valle Eds.: 4829-4856. McGraw-Hill New York
10. Hixson, P., C.W. Smith, S.B. Shurin, & M.F. Tosi 2004. Unique CD18 mutations involving a deletion in the extracellular and a major truncation of the cytoplasmic domain in patients with leukocyte adhesion deficiency type 1. Blood 103: 1105-1110.
11. Uzel, G., E. Tin, S.D. Rosenzweig, et al 2008. Reversion mutations in patients with leukocyte adhesion deficiency type I (LAD-1). Blood 111: 209-218.
12. Shuster, D.E., M.E. Kehrli, Jr., M.R. Ackermann & R.O. Gilbert 1992. Identification and prevalence of a genetic defect that causes leukocyte adhesion deficiency in Holstein cattle. Proc. Natl. Acad. Sci. USA 89: 9225-9229.
13. Giger, U., L.A. Boxer, P.J. Simpson, et al 1987. Deficiency if leukocyte surface glycoproteins Mo1, LFA-1 and Leu M5 in a dog with recurrent bacterial infections: an animal model. Blood 69: 1622-1630.
14. Etzioni, A., C.M. Doerschuk & J.M. Harlan 1999. Of man and mouse: leukocyte and endothelial adhesion molecules deficiencies. Blood 94: 3281-3288.
15. Etzioni, A. & J.M. Harlan 2007. Cell adhesion and leukocyte adhesion defects. In Primary Immune Deficiency Disease. A Molecular and Genetic Approach, 2nd ed. E.M. Smith, J. Puck & H.D. Ochs, eds.: 550-564. Oxford University Oxford, New York
16. Qasim, W., M. Cavazzan-Calvo, G. Davies, et al 2009. Allergenic hematopoietic stem cell transplantation for leukocyte adhesion deficiency. Pediatrics 123: 836-840.
17. Bauer, T.R., J.M. Allen, M. Hai, et al 2008. Successful treatment of canine leukocyte adhesion deficiency by foamy virus vector. Nat. Med. 14: 93-97.
18. Hunter, J.M, H. Zhao, L.M. Tuschong, et al 2011. Gene therapy for canine leukocyte adhesion deficiency with lentiviral vectors using the murine stem cell virus and human phosphoglycerate kinase promoters. Hum. Gene Therap. 22: 689-696.
19. Yakubenia, S. & M.K. Wild 2006. Leukocyte adhesion deficiency II. Advances and open questions. FEBS J. 273: 4390-4398.
20. Lubke, T., T. Marquardt, A. Etzioni, et al 2001. Complementation cloning identified CDG-IIc, a new type of congenital disorder of glycosylation as a GDP-fucose transporter deficiency. Nat. Gen. 28: 73-76.
21. Luhn, K., M.K. Wild, M. Eckhardt, et al 2001. The gene defective in leukocyte adhesion deficiency II encoded a putative GDP-fucose transporter. Nat. Gen. 28: 69-72.
22. Caffaro, L.E. & C.B. Hirschberg 2006. Nucleotide sugar transporters of the Golgi apparatus: from basic science to diseases. Acc. Chem. Res. 39: 805-812.
23. Helmus, Y., J. Denecke, S. Yakubenia, et al 2006. Leukocyte adhesion deficiency II patients with a dual defect in the GDP-fucose transporter. Blood 107: 3959-3966.
24. Hellbusch, C.C., M. Sperandio, D. Formmhold, et al 2007. Golgi GDP fucose transporter-deficient mice mimic congenital disorder of glycosylation IIc/leukocyte adhesion deficiency II. J. Biol. Chem. 282: 10762-10772.
25. Marquardt, T., K. Luhn, G. Srikrishna, et al 1999. Correction of leukocyte adhesion deficiency type II with oral fucose. Blood 94: 3976-3985.
26. Hidalgo, A., S. Ma, A.J. Peired, et al 2003. Insights into leukocyte adhesion deficiency type 2 from a novel mutation in the GDP-fucose transporter gene. Blood 101: 1705-1712.
27. Etzioni, A. & M. Tonetti 2000. Fucose supplementation in leukocyte adhesion deficiency type II. Blood 95: 3641-3643.
28. Chenn A. 2009. A top Notch want to make astrocytes. Dev Cell. 16: 158-159.
29. Ishikawa, H.O., S. Higashi, T. Ayukawa, et al 2005. Notch deficiency implicated in the pathogenesis of gongenital disorder of glycosylation IIc. Proc. Natl. Acad. Sci. USA 102: 18532-18537.
30. Pessach, I.M., J. Ordovas-Montanes, S.Y. Zhang, et al 2011. Induced pluripotent stem cells: a novel frontier in the study of human primary immunodeficiencies. J. Allergy Clin. Immunol. 127: 1400-1407.
31. Alon, R. & A. Etzioni 2003. LAD III a novel group of leukocyte integrin activation deficiencies. Trends Immunol. 24: 561-566.
32. Kilic, S.S. & A. Etzioni 2009. The clinical spectrum of leukocyte adhesion deficiency (LAD III) due to defective CalDAGGEF1. J. Clin. Immunol. 29: 117-122.
33. Elhasid, R., S.S. Kilic, M. Ben-Harush, et al 2010. Prompt recovery of recipient hematopoiesis following two consecutive haploidentical peripheral blood stem cell transplantation in a child with leukocyte adhesion deficiency III (LAD III) syndrome. Bone Marrow Transplant. 45: 413-414.
34. Luo, B.H., C.V. Carman & T.A. Springer 2007. Structural basis of integrin regulation and signaling. Annu. Rev. Immunol. 25: 619-647.
35. Kuijpers, T.W., R. Van Bruggen, N. Kamerleek, et al 2007. Natural history and early diagnosis of LAD I/variant syndrome. Blood 109: 3529-3537.
36. Moser, M., B. Nieswandt, S. Ussar, et al 2008. Kidlin3 is essential for integrin activation and platelet aggregation. Nat. Med. 14: 325-330.
37. Ye, F. & B.G. Petrich 2011. Kindlin: helper, co-activator, or booster of talin in integrin activation? Curr. Opin. Hematol. JULY 1 18: 356-360.
38. Moser, M., M. Bauer, S. Schmid, et al 2009. Kindlin3 is required for beta 2 integrin mediated leukocyte adhesion to endothelia cells. Nat. Med. 15: 300-305.
39. Hogg, N., I. Patzak & F. Willenbrock 2011. The insider's guide to leukocyte integrin signaling and function. Nat. Rev. Immunol. 11: 416-426.
40. Svensson, L., K. Howarth, A. McDowall, et al 2009. Leukocyte adhesion deficiency III is caused by mutations in Kindlin3 affects integrin activation. Nat. Med. 15: 306-312.
41. Schmidt, S., I. Nakchbandi, R. Ruppert, et al 2011. Kindlin-3-mediated signaling from multiple integrin classes is required for osteoclast-mediated bone resorption. J. Exp. Med. 192: 883-897.
42. Molinin, N.L., L. Zhang, J. Choi, et al 2009. A point mutation in Kindlin3 ablated activity of three integrin subfamilies in humans. Nat Med. 15: 313-318.
43. Mory, A., S.W. Feigelson, N. Yarali, et al 2008. Kindlin3 a new gene involved in the pathogenesis of LAD III. Blood 112: 2591.
44. McDowall A., L. Svensson, P. Stanley, et al 2010. Two mutations in the KINDLIN3 gene of a new leukocyte adhesion deficiency III patient reveal distinct effects on leukocyte function in vitro. Blood 115: 4834-4842.
45. Posvolsky, R., S.W. Feigelson, S.S. Kilic, et al 2007. A LAD III syndrome is associated with defective expression of the Rap1 activator CalDAGGEF1 in lymphocytes, neutrophils and platelets. J. Exp. Med. 204: 1571-1582.
46. Bergmeier, W., T. Goerge, H.W. Wang, et al 2007. Mice lacking the signaling molecule CalDAGGEF1 represent a model for leukocyte adhesion deficiency type III. J. Clin. Invest. 117: 1699-1707.